MET · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.44B | $2.25B | $2.23B | $2.11B | $2.07B | $1.35B | $1.29B | $1.26B |
| Selling, General & Administrative | $560.00M | $481.00M | $828.00M | $669.00M | $670.00M | $761.00M | $901.00M | $910.00M |
| Operating Expenses | $13.86B | $13.02B | $12.71B | $11.86B | $12.02B | $13.15B | $13.69B | $13.71B |
| Operating Income | $6.14B | $6.00B | $5.72B | $5.98B | — | — | — | — |
| Interest Expense | $724.00M | $738.00M | $740.00M | $655.00M | $647.00M | $632.00M | $656.00M | $827.00M |
| Income Before Taxes | $4.66B | $5.62B | $2.16B | $6.36B | $8.52B | $6.93B | $6.79B | $6.31B |
| Provision for Income Taxes | $1.26B | $1.18B | $560.00M | $1.06B | $1.64B | $1.51B | $886.00M | $1.18B |
| Net Income | $3.17B | $4.23B | $1.38B | $2.35B | $6.35B | $5.41B | $5.90B | $5.12B |
| Basic EPS | $4.74 | $5.98 | $1.82 | $6.35 | $7.71 | $5.72 | $6.10 | $4.95 |
| Diluted EPS | $4.71 | $5.94 | $1.81 | $6.30 | $7.65 | $5.68 | $6.06 | $4.91 |
| Basic Shares Outstanding | 668.90M | 706.40M | 757.70M | 803.20M | 862.70M | 907.80M | 937.60M | 1.01B |
| Diluted Shares Outstanding | 673.30M | 711.10M | 762.30M | 808.90M | 869.40M | 913.20M | 944.40M | 1.01B |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $9.89 | $9.71 | $10.25 | 10 | ↑1 ↓6 |
| Dec 2027 | $10.94 | $10.71 | $11.50 | 10 | ↑0 ↓3 |
| Dec 2028 | $12.20 | $12.00 | $12.40 | 4 | ↑0 ↓0 |